401 related articles for article (PubMed ID: 35039976)
1. Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.
Park J; Wu Z; Steiner PR; Zhu B; Zhang JXJ
Ann Biomed Eng; 2022 Feb; 50(2):111-137. PubMed ID: 35039976
[TBL] [Abstract][Full Text] [Related]
2. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
[TBL] [Abstract][Full Text] [Related]
3. Organ-on-a-chip platforms as novel advancements for studying heterogeneity, metastasis, and drug efficacy in breast cancer.
Kalot R; Mhanna R; Talhouk R
Pharmacol Ther; 2022 Sep; 237():108156. PubMed ID: 35150784
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Organ-on-Chips Integrated with Bioprinting Technologies for Drug Screening.
Tabatabaei Rezaei N; Kumar H; Liu H; Lee SS; Park SS; Kim K
Adv Healthc Mater; 2023 Aug; 12(20):e2203172. PubMed ID: 36971091
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.
Portillo-Lara R; Spencer AR; Walker BW; Shirzaei Sani E; Annabi N
Biomaterials; 2019 Apr; 198():78-94. PubMed ID: 30201502
[TBL] [Abstract][Full Text] [Related]
6. Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.
Mohammadi MH; Heidary Araghi B; Beydaghi V; Geraili A; Moradi F; Jafari P; Janmaleki M; Valente KP; Akbari M; Sanati-Nezhad A
Adv Healthc Mater; 2016 Oct; 5(19):2459-2480. PubMed ID: 27548388
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening approaches and combinatorial development of biomaterials using microfluidics.
Barata D; van Blitterswijk C; Habibovic P
Acta Biomater; 2016 Apr; 34():1-20. PubMed ID: 26361719
[TBL] [Abstract][Full Text] [Related]
8. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
Bhagat S; Singh S
Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
[TBL] [Abstract][Full Text] [Related]
9. Engineered platforms for mimicking cardiac development and drug screening.
Stiefbold M; Zhang H; Wan LQ
Cell Mol Life Sci; 2024 Apr; 81(1):197. PubMed ID: 38664263
[TBL] [Abstract][Full Text] [Related]
10. Heart-on-a-chip systems: disease modeling and drug screening applications.
Butler D; Reyes DR
Lab Chip; 2024 Feb; 24(5):1494-1528. PubMed ID: 38318723
[TBL] [Abstract][Full Text] [Related]
11. Sensors in heart-on-a-chip: A review on recent progress.
Cho KW; Lee WH; Kim BS; Kim DH
Talanta; 2020 Nov; 219():121269. PubMed ID: 32887159
[TBL] [Abstract][Full Text] [Related]
12. Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications.
Wu H; Shi S; Liu Y; Zhang Q; Lam RHW; Lim CT; Hu J
Biofabrication; 2023 Jul; 15(4):. PubMed ID: 37267929
[TBL] [Abstract][Full Text] [Related]
13. Engineering Cardiac Tissue for Advanced Heart-On-A-Chip Platforms.
Chen X; Liu S; Han M; Long M; Li T; Hu L; Wang L; Huang W; Wu Y
Adv Healthc Mater; 2024 Jan; 13(1):e2301338. PubMed ID: 37471526
[TBL] [Abstract][Full Text] [Related]
14. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.
Conant G; Lai BFL; Lu RXZ; Korolj A; Wang EY; Radisic M
Stem Cell Rev Rep; 2017 Jun; 13(3):335-346. PubMed ID: 28429185
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic organ-on-a-chip models of human liver tissue.
Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development.
Li Z; Hui J; Yang P; Mao H
Biosensors (Basel); 2022 May; 12(6):. PubMed ID: 35735518
[TBL] [Abstract][Full Text] [Related]
17. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
18. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
[TBL] [Abstract][Full Text] [Related]
19. Cell-Based Assays on Microfluidics for Drug Screening.
Liu X; Zheng W; Jiang X
ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
[TBL] [Abstract][Full Text] [Related]
20. In silico modeling of endocrine organ-on-a-chip systems.
Sung B
Math Biosci; 2022 Oct; 352():108900. PubMed ID: 36075288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
